BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12913983)

  • 1. [The use of cardioselective beta-adrenoblocker bisoprolol in patients with chronic heart failure].
    Ol'binskaia LI; Ignatenko SB
    Kardiologiia; 2003; 43(2):56-9. PubMed ID: 12913983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk reduction of acute heart failure with initial administration of beta-blockers].
    Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic heart failure and sudden death: the message of CIBIS-III].
    Dequarti MC; Poggio L; Vanoli E
    Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of essential arterial hypertension].
    Girerd X
    Presse Med; 2000 Nov; 29(34):1856-8. PubMed ID: 11709818
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL; van Veldhuisen DJ; Goulder M; Zilahi Z; Meyer WR; Willenheimer R
    Int J Cardiol; 2010 Sep; 144(1):59-63. PubMed ID: 19481278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
    Krum H; van Veldhuisen DJ; Funck-Brentano C; Vanoli E; Silke B; Erdmann E; Follath F; Ponikowski P; Goulder M; Meyer W; Lechat P; Willenheimer R;
    Cardiovasc Ther; 2011 Apr; 29(2):89-98. PubMed ID: 20528880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
    MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
    [No Abstract]   [Full Text] [Related]  

  • 13. Bisoprolol in chronic heart failure.
    Davis M
    Hosp Med; 2000 Feb; 61(2):120-3. PubMed ID: 10748791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, hemodynamic and neurohumoral effects of long-term therapy of patients with severe chronic heart failure with beta-adrenoblocker bisoprolol].
    Belenkov IuN; Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Narusov OIu; Baklanova NA; Masenko VP
    Kardiologiia; 2003; 43(10):10-21. PubMed ID: 14593351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
    Willenheimer R; Erdmann E; Follath F; Krum H; Ponikowski P; Silke B; Van Veldhuisen DJ; Van De Ven L; Verkenne P; Lechat P;
    Eur J Heart Fail; 2004 Jun; 6(4):493-500. PubMed ID: 15182776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of candesartan, enalapril and their combination in congestive heart failure].
    Rapezzi C
    Ital Heart J Suppl; 2000 Mar; 1(3):429-30. PubMed ID: 10815278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rational diagnostics and current treatment concepts in the management of chronic heart failure].
    Weil J
    Med Klin (Munich); 2008 Sep; 103(9):646-62; quiz 663-4. PubMed ID: 18813888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of the month. The CIBIS-II study].
    Kulbertus H
    Rev Med Liege; 1999 Feb; 54(2):128-9. PubMed ID: 10221068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.